INTS vs ZBRA · $7.7M cap vs P/E 28, rev $4.98B
Intensity Therapeutics, Inc. Common stock (INTS) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported ZBRA revenue for 2024-12-31 was $4.98B. Net income was $528.0M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
INTS currently screens at market cap $7.7M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the INTS and ZBRA stock pages for the full models.
Not investment advice.